Michael F. Drummond
Werke:
- Commentary: Advocating for patient and public involvement and engagement in health economic evaluation
- The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review
- Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches
- Establishing a reasonable price for an orphan drug